Analysis using next generation sequencing (NGS) of primary refractory or relapsing patients with mature B-cell malignancies treated by immunochemotherapy and data integration to tailor therapeutic strategies in the setting of the cooperative group LYSA (The Lymphoma Study Association)
FunderInstitut National du Cancer
Duration20 Jan 2014 - 20 Jan 2017
Funded underTRANSLA
Call for proposalTRANSLA13
Project codeINCa-6883
Open Access mandatePublications: NoResearch data: No